Roundhill GLP-1 & Weight Loss ETF Rating $30.56 -0.29 (-0.94%) As of 06/12/2026 03:57 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.62Holdings in OZEM have an aggregate rating of Moderate Buy based on 275 analyst ratings issued in the past year covering 14 companies (64.0% of the portfolio).OZEM Aggregate Price Target$30.56High Prediction$30.56Average Prediction$30.56Low Prediction$30.56Holdings in OZEM have an aggregate price target of $30.56 and a range of $30.56 to $30.56 covering 14 companies (64.0% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 14 OZEM Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings19.32%LLYEli Lilly and Company$1,137.01-2.1%4.3733 of 5 stars2.87$1,227.74 8.0%30Trending NewsAnalyst ForecastAnalyst Revision12.85%NVONovo Nordisk A/S$43.90-0.1%4.2227 of 5 stars2.13$65.56 49.3%23Trending NewsAnalyst Revision6.61%PFEPfizer$26.19+0.1%3.6632 of 5 stars2.25$28.82 10.1%20Trending NewsAnalyst Upgrade4.33%VKTXViking Therapeutics$28.75+0.5%2.4597 of 5 stars2.79$93.60 225.6%143.89%KLRAKailera Therapeutics$18.89-3.3%4.7136 of 5 stars3.00$42.75 126.3%73.81%AMGNAmgen$355.20+0.3%3.7973 of 5 stars2.48$354.12 -0.3%31Trending NewsAnalyst Forecast2.63%REGNRegeneron Pharmaceuticals$612.14+0.1%4.8575 of 5 stars2.70$792.65 29.5%27Positive News2.55%GPCRStructure Therapeutics$42.93-0.9%2.9499 of 5 stars2.89$106.75 148.7%19Analyst Forecast2.05%MBXMBX Biosciences$35.51-4.7%2.3228 of 5 stars2.77$60.22 69.6%13News CoverageGap DownHigh Trading Volume1.84%BHVNBiohaven$11.34-0.2%2.6329 of 5 stars2.71$22.27 96.3%171.71%GILDGilead Sciences$125.59-0.2%4.9214 of 5 stars2.86$156.93 25.0%29Trending NewsAnalyst ForecastOptions VolumeAnalyst Revision1.50%RYTMRhythm Pharmaceuticals$88.38+0.8%2.5629 of 5 stars2.83$131.81 49.1%18News CoverageGap Down0.71%WVEWAVE Life Sciences$5.87+1.0%3.1031 of 5 stars2.87$26.41 349.9%15News CoverageAnalyst Forecast0.24%CRBPCorbus Pharmaceuticals$8.19+5.3%3.9703 of 5 stars2.75$42.00 412.8%12 This page (NASDAQ:OZEM) was last updated on 6/14/2026 by MarketBeat.com Staff. From Our PartnersCatch it while it's openA few times a year, Bill Poulos makes his book Simple Options Trading for Beginners available at no cost. It n...Profits Run | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsTucked inside U.S. Code Title 31, Section 5117 is a provision allowing the Treasury to reprice America's gold ...Americas Gold Company | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThe S-1 disclosure Wall Street is racing to traceWhen SpaceX filed its S-1, the SEC required full disclosure of costs - and power consumption for 1 million GPU...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
